Cure My Disease

Don't miss your cure!

 Log in / Sign up

New injection aims to regrow hair in patchy baldness

NCT ID NCT06826196

Recruiting now Symptom relief Sponsor: Aldena Therapeutics Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests whether ALD-102, a solution injected into the scalp, is safe and can help regrow hair in people with alopecia areata. About 24 adults aged 18-55 will receive either the drug, a placebo (saline), or no treatment in different scalp areas. The main goal is to check for side effects, while also looking for signs of hair regrowth.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA(AA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alopecia areata

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALOPECIA AREATA(AA)

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Centre de Recherche Saint-Louis

    RECRUITING

    Québec, Quebec, QC G1W 4R4, Canada

  • Clinical Trial Research Institute

    RECRUITING

    Thousand Oaks, California, 91320, United States

    Contact Email: •••••@•••••

  • Dermatology Specialists of Spokane

    RECRUITING

    Spokane, Washington, 99202, United States

  • Innovaderm

    RECRUITING

    Montreal, Quebec, H2X 2V1, Canada

  • Options Research Group

    RECRUITING

    West Lafayette, Indiana, 47906, United States

  • The Brigham and Women's Hospital

    RECRUITING

    Boston, Massachusetts, 02115, United States

  • The Centre for Clinical Trials

    RECRUITING

    Oakville, Ontario, L6J 7W5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.